Cutler Group LP Ngm Biopharmaceuticals Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Cutler Group LP holds 3,100 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,100

Previous 3,100 -0.0%

Holding current value

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$3.72 - $5.4 $3,720 - $5,400	1,000 Added 47.62%	3,100 $12,000
Q4 2022 Feb 07, 2023	BUY	$3.41 - $12.93 $2,387 - $9,051	700 Added 50.0%	2,100 $10,000
Q3 2022 Oct 25, 2022	BUY	$12.59 - $17.67 $16,367 - $22,971	1,300 Added 1300.0%	1,400 $18,000
Q2 2022 Aug 04, 2022	SELL	$10.58 - $17.5 $17,986 - $29,750	-1,700 Reduced 94.44%	100 $1,000
Q3 2021 Oct 26, 2021	BUY	$20.15 - $26.19 $16,119 - $20,952	800 Added 80.0%	1,800 $37,000
Q2 2021 Jul 19, 2021	SELL	$15.06 - $30.03 $16,566 - $33,033	-1,100 Reduced 52.38%	1,000 $19,000
Q1 2021 Apr 26, 2021	BUY	$24.99 - $31.93 $2,499 - $3,193	100 Added 5.0%	2,100 $61,000
Q4 2020 Jan 21, 2021	BUY	$16.21 - $31.44 $25,936 - $50,304	1,600 Added 400.0%	2,000 $60,000
Q2 2020 Jul 22, 2020	BUY	$11.97 - $23.47 $4,788 - $9,388	400 New	400 $7,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account